radiopharma rival Lantheus competitors & alternatives

Pharmaceuticals

Telix Pharmaceuticals is a commercial-stage biopharmaceutical company headquartered in Melbourne, Australia, focused on the development of diagnostic and therapeutic radiopharmaceuticals.

PENTIXAPHARM HLDGPTP · PharmaceuticalsGermany

69% matchPublic

Pharmaceuticals

Pentixapharm Holding AG is a clinical-stage radiopharmaceutical company that develops first-in-class radiopharmaceutical diagnostics and therapeutics, focusing on CXCR4-targeted compounds. The company serves patients and healthcare providers by advancing drug candidates through clinical trials, including Phase III-ready programs.

Pharmaceuticals

Advanced Accelerator Applications (AAA) is a French pharmaceutical company focused on molecular nuclear medicine, developing and manufacturing radiopharmaceuticals for diagnosis and targeted cancer treatment. Its products include Lutathera and diagnostic agents such as NETSPOT, serving oncology and nuclear-medicine clinicians and patients; AAA was acquired by Novartis in 2018.

ROCHE I1RO · Pharmaceuticals

66% matchPublic

Pharmaceuticals

Roche is a healthcare company that develops and provides pharmaceuticals and diagnostic solutions. It focuses on preventing, diagnosing, and treating severe health conditions such as cancer, cardiovascular-metabolic diseases, and neurological disorders for patients worldwide.

Healthcare

PD Theranostics, Inc. (operating as United Theranostics) provides molecular imaging and precision radiopharmaceutical therapy for cancer patients, specializing in treatments for prostate cancer, neuroendocrine tumors, and thyroid cancer. The company utilizes advanced diagnostics such as PET and SPECT scans combined with targeted radiopharmaceuticals to deliver personalized, outpatient treatment plans. Additionally, they participate in clinical trials and collaborate with referring providers to offer innovative cancer care options.

Radiopharm Theranostics LtdRADX · BiotechCarlton, Australia

72% matchPublic

Biotech

Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions. The company's diverse pipeline features: RAD 204, designed to target PD-L1 for non-small cell lung cancer; RAD 202, aimed at HER2 for breast cancer and other solid tumor types; and two avß6 integrin-targeting agents, RAD 301 (a diagnostic tool for pancreatic ductal adenocarcinoma) and RAD 302 (a therapeutic agent for various cancers). Other significant developments include RAD 101 and RAD 102 for brain metastases, RAD 402 for advanced prostate cancer, and RV01 for multiple solid tumors. To accelerate the clinical progression of its radiopharmaceutical assets, Radiopharm Theranostics maintains a strategic partnership with Lantheus Holdings, Inc.

Newrite MedicalMedical Technology

69% match

Medical Technology

Newrite Medical is a developer of targeted therapeutic and diagnostic agents for nuclear medicine applications. The company provides radiopharmaceutical development, isotope production, and radioligand therapy technologies.

ITM Isotope Technologies Munich SEBiotechnologyGermany

66% match

Biotechnology

ITM Isotope Technologies Munich SE is a radiopharmaceutical biotech company based in Garching bei München, Germany. It develops, produces, and globally supplies targeted radiotherapeutic and diagnostic agents for cancer treatment. The company notably secured a major €255 million investment round to further advance its clinical pipeline.

Roche DiagnosticsHealthcare TechnologySwitzerland

66% match

Healthcare Technology

Roche is a healthcare company that develops and provides pharmaceuticals and diagnostic solutions to patients and healthcare professionals. The company focuses on preventing, diagnosing, and treating complex diseases such as cancer, cardiovascular-metabolic conditions, and neurological disorders.

Ipsen0MH6 · PharmaceuticalsUnited Kingdom

69% matchPublicAI 19/100 ▲Green 30/100

Pharmaceuticals

Ipsen is a global biopharmaceutical company that researches, develops, and commercializes innovative medicines. It primarily serves patients suffering from conditions in the fields of oncology, rare diseases, and neuroscience.

Bracco Imaging S.p.A.PharmaceuticalsItaly

69% match

Pharmaceuticals

Bracco Imaging S.p.A. develops, manufactures, and markets diagnostic imaging solutions, including contrast agents and medical devices. The company serves the global healthcare industry by providing advanced imaging tools and technologies designed to improve clinical outcomes for professionals and patients.

Bristol-Myers Squibb Company Celegne Contingent ValueCELG.R · PharmaceuticalsUnited States

68% matchPublic

Pharmaceuticals

Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers transformational medicines for patients with serious diseases. The company focuses on therapeutic areas including oncology, hematology, neuroscience, immunology, and cardiovascular research.